AZN - Astrazeneca PLC Stock Trading

Astrazeneca PLC(NYSE: AZN) stock trading, description, contact, officers and directors.

About Astrazeneca PLC

Not available

Stock Information

Astrazeneca PLC Company Name:

AZN Stock Symbol:

NYSE Market:

Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...

AZN - ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

Ground-breaking Phase III head-to-head DESTINY-Breast03 results featured at ESMO Presidential Symposium support ENHERTU as the potential new standard of care in previously treated patients DESTINY-Breast01 Phase II trial data also presented at ESMO showed impressive ...
AZN - ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated robust and durable tumor response of 54.9% in patients with HER2-mutant metastatic non-small cell lung cancer

First HER2-directed therapy to show a strong tumor response in this population Data from HER2-mutant cohort of pivotal DESTINY-Lung01 Phase II trial presented at ESMO and published in The New England Journal of Medicine Detailed primary results from t...
AZN - Here's Why Innate Pharma Stock Is Rocketing Higher Today

Shares of Innate Pharma (NASDAQ: IPHA) , a clinical-stage biotechnology company, are rocketing higher in response to successful clinical-trial data for an experimental cancer drug called monalizumab. Investors surprised by the results pushed the stock 107.8% higher when the market o...